FDA DEVICE FACTS
Sterile Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (Blue); Sterile Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (Blue) – Extended Cuff
Hartalega NGC Sdn. Bhd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Sterile Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs and Fentanyl] Citrate (Blue); and Sterile Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs and Fentanyl] Citrate (Blue) - Extended Cuff, is a sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner.
These gloves were tested for use with chemotherapy drugs and fentanyl citrate as per ASTM D6978 Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs.
Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time in Minutes Carmustine (3.3 mg/ml) 38.3 Cisplatin (1.0 mg/ml) > 240 Cyclophosphamide (20.0 mg/ml) > 240 Dacarbazine (10.0 mg/ml) > 240 Doxorubicin HCI (2.0 mg/ml) > 240 Etoposide (20.0 mg/ml) > 240 Fluorouracil (50.0 mg/ml) > 240 Methotrexate (25.0 mg/ml) > 240 Mytomycin C (0.5 mg/ml) > 240 Paclitaxel (6.0 mg/ml) > 240 Thiotepa (10.0 mg/ml) 78.6 Vincristine Sulfate (1.0 mg/ml) > 240 Vidaza (5-Azacytidine), 25 mg/ml >240 Busulfan, 6 mg/ml >240 Carboplatin, 10 mg/ml >240 Docetaxel, 10 mg/ml >240 Epirubicin HCl, 2 mg/ml >240 Gemcitabine HCl, 38 mg/ml >240 Ifosfamide, 50 mg/ml >240 Irinotecan, 20 mg/ml >240 Mitoxantrone HCl, 2 mg/ml >240 Oxaliplatin, 5 mg/ml >240 Vinorelbine, 10 mg/ml >240 Fentanyl Citrate and Concentration Minimum Breakthrough Detection Time in Minutes Fentanyl Citrate Injection (100mcg/2ml) >240
Caution: Testing showed a minimum breakthrough time of 38.3 minutes with Carmustine and 78.6 minutes with Thiotepa. Warning: Do not use with Carmustine
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。